CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Levodopa / carbidopa

Last Updated: December 19, 2008
Result type: Reports
Project Number: SR0154-000
Product Line: Reimbursement Review

Generic Name: Levodopa / carbidopa

Brand Name: Duodopa

Manufacturer: Solvay Pharma Inc.

Therapeutic Area: Parkinson's disease

Indications: Parkinson's disease

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: July 22, 2009

Recommendation Type: Do not list